Ausgabe 2/2024
Inhalt (25 Artikel)
European Society of Clinical Pharmacy: ‘Implementing and scaling sustainable clinical pharmacy’
Michael Scott, Kamila Urbańczyk, Derek Stewart
The effectiveness of ibandronate in reducing the risk of nonvertebral fractures in women with osteoporosis: systematic review and meta-analysis of observational studies
Carlos Alves, Diogo Mendes, Ana Penedones, Tânia Oliveira, António Donato, Francisco Batel-Marques
The prevalence of hepatic and thyroid toxicity associated with imatinib treatment of chronic myeloid leukaemia: a systematic review
Mansour Tobaiqy, Nawal Helmi, Katie MacLure, Sylvia Saade
Real-world data of atezolizumab in patients with previously treated locally advanced or metastatic urothelial bladder cancer
Rocío Díaz Acedo, Mercedes Galvan Banqueri, Silvia Artacho Criado, Eva María Fernández Parra, Rocío Jiménez Galán, Ana Isabel Gago Sánchez, Juan Francisco Marín Pozo, María José Martínez Bautista
Management of iron deficiency in women of childbearing age with oral iron intolerance: a prospective, randomised, controlled trial of three doses of an iron-whey-protein formulation
Mark Ledwidge, Fiona Ryan, Anna Seoighe, Maria Jose Santos-Martinez, Cristin Ryan, J. G. F. Gilmer
Accuracy in patient-reported adverse drug reactions and their recognition: a mixed-methods study
Sirinya Kampichit, Warisara Srisuriyachanchai, Thongchai Pratipanawatr, Narumol Jarernsiripornkul
Discrepancies among equations to estimate the glomerular filtration rate for drug dosing decision making in aged patients: a cross sectional study
M. Margarida Castel-Branco, Marta Lavrador, Ana C. Cabral, Adriana Pinheiro, Joana Fernandes, Isabel Vitória Figueiredo, Fernando Fernandez-Llimos
Comparison of the incidence of nausea and vomiting between linezolid and vancomycin using claims database: a retrospective cohort study
Takezo Tsutsumi, Shungo Imai, Kenji Momo, Hitoshi Kashiwagi, Yuki Sato, Mitsuru Sugawara, Yoh Takekuma
Evaluating the impact of PD-1 inhibitor treatment on key health outcomes for cancer patients in China
Pei Zhang, Lingli Zhang, Kai Xu, Yingtao Lin, Rui Ma, Mengdie Zhang, Xin Li
Communication skills-based training about medication switch encounters: pharmacy staff and patients’ experiences
Laura Schackmann, Ellen S. Koster, Liset van Dijk, Marcia Vervloet, Mette Heringa
Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach
Martin Luke Canning, Michael Barras, Ross McDougall, Stephanie Yerkovich, Ian Coombes, Clair Sullivan, Karen Whitfield
Comparison of the sensitivities of pharmacotherapy-related and disease-specific quality of life measures in response to pharmacist-led pharmaceutical care for cancer outpatients: a randomised controlled trial
Phantipa Sakthong, Porntip Soipitak, Win Winit-Watjana
Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database
Sha Zhang, Yidong Wang, Zhan Qi, Shanshan Tong, Deqiu Zhu
Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system
Yibei Zhao, Huiming Jiang, Lifen Xue, Mi Zhou, Xiaobing Zhao, Fei Liu, SongJiang Jiang, Jing Huang, Long Meng
Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database
Mansour Tobaiqy, Hajer Elkout
Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis
Mégane Jermini, Caroline Fonzo-Christe, Katherine Blondon, Christelle Milaire, Jérôme Stirnemann, Pascal Bonnabry, Bertrand Guignard
Pharmacists working in residential aged care: a survey of pharmacist interest and perceived preparedness
Amanda J. Cross, Deborah Hawthorne, Lisa Kouladjian O’Donnell, Kenneth Lee, Amy Theresa Page
First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database
Kenneth L. McCall, Bennett J. Doughty, Brian J. Piper, Heeral Naik, Seraphine Bange, Emily E. Leppien
A cohort study comparing pharmacist activities during participation in general medical ward rounds: telehealth versus in-person during the COVID-19 pandemic
Meng Yap, Gail Edwards, Harry Gibbs, Harvey Newnham, Nicole Hancock, Erica Y. Tong
Screening for atrial fibrillation in care homes using pulse palpation and the AliveCor Kardia Mobile® device: a comparative cross-sectional pilot study
V. Savickas, A. J. Stewart, V. J. Short, A. Mathie, S. K. Bhamra, E. L. Veale, S. A. Corlett
A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases
Tatsuaki Takeda, Shiho Sugimoto, Jun Matsumoto, Naohiro Iwata, Akihiko Nakamoto, Aya Fukuma Ozaki, Hirofumi Hamano, Noritaka Ariyoshi, Yoshito Zamami
Barriers to person-centered service design in pharmacy practice: examples, lessons, and potential solutions
Logan T. Murry, Shane P. Desselle
Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy
Francesca Wirth, Cathal A. Cadogan, Daniela Fialová, Ankie Hazen, Monika Lutters, Vibhu Paudyal, Anita E. Weidmann, Betul Okuyan, Martin C. Henman
Correction: Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy
Francesca Wirth, Cathal A. Cadogan, Daniela Fialová, Ankie Hazen, Monika Lutters, Vibhu Paudyal, Anita E. Weidmann, Betul Okuyan, Martin C. Henman